Literature DB >> 16647984

Factors contributing to nasal allergic late phase eosinophilia.

Matthias F Kramer1, Thorsten R Jordan, Christine Klemens, Eva Hilgert, John M Hempel, Elisabeth Pfrogner, Gerd Rasp.   

Abstract

OBJECTIVE: This study focused on factors contributing to eosinophilia after intranasal allergen challenge.
METHODS: Nasal secretions of 13 allergic individuals were gained over a period of 8 hours after nasal allergen challenge. Early and late phase reactions were determined by acoustic rhinometry and changes of volume and total protein in nasal secretions. Eosinophilia was demonstrated by nasal eosinophilic cationic protein. Interleukin (IL)-5; the chemokines IL-8, monocyte chemotactic protein (MCP)-1 and MCP-3, and eotaxin; soluble vascular cell adhesion molecule 1 (sVCAM-1); and the leukotriene C4 (LTC4) were analyzed by enzyme-linked immunosorbent assay for their suggested impacts on tissue eosinophilia.
RESULTS: By means of rhinometry, we observed in 69% an alternating type of late phase response, followed by a bilateral (15%) or unilateral (8%) type. A biphasic kinetic could be demonstrated by changes in nasal volume and total protein of nasal secretions, reflecting the early and late phase responses. A typical late phase kinetic was observed for IL-5, MCP-1, eotaxin, sVCAM-1, and LTC4. Interleukin 8 was characteristic for early phase reaction but increased in late phase as well. We could not detect any MCP-3 in our samples.
CONCLUSIONS: Our data point to a relevant role of the T(H)2 cytokine IL-5; of the chemokines IL-8, MCP-1, and eotaxin; of the adhesion molecule sVCAM-1; and of the leukotriene LTC4 for the allergic late phase eosinophilia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16647984     DOI: 10.1016/j.amjoto.2005.09.013

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  12 in total

1.  [The NTP in allergy research : open questions regarding nasal provocation tests using allergens].

Authors:  U Förster; A Sperl; L Klimek
Journal:  HNO       Date:  2013-10       Impact factor: 1.284

2.  Specific probiotics alleviate allergic rhinitis during the birch pollen season.

Authors:  Arthur C Ouwehand; Merja Nermes; Maria Carmen Collado; Nina Rautonen; Seppo Salminen; Erika Isolauri
Journal:  World J Gastroenterol       Date:  2009-07-14       Impact factor: 5.742

Review 3.  Thioredoxin-1: A Promising Target for the Treatment of Allergic Diseases.

Authors:  Jinquan Wang; Jiedong Zhou; Cuixue Wang; Atsushi Fukunaga; Shujing Li; Junji Yodoi; Hai Tian
Journal:  Front Immunol       Date:  2022-04-28       Impact factor: 8.786

4.  A case of occupational rhinitis caused by rice powder in the grain industry.

Authors:  Joo-Hee Kim; Jeong Eun Kim; Gil-Soon Choi; Eui-Kyung Hwang; Soyeon An; Young-Min Ye; Hae-Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2010-03-24       Impact factor: 5.764

5.  2-(4-{2-[(phenylthio)acetyl]carbonohydrazonoyl}phenoxy)acetamide as a new lead compound for management of allergic rhinitis.

Authors:  Hee-Yun Kim; Sun-Young Nam; Jae-Bum Jang; Youngjin Choi; In-Cheol Kang; Hyung-Min Kim; Hyun-Ja Jeong
Journal:  Inflamm Res       Date:  2016-08-11       Impact factor: 4.575

6.  Reproducibility of nasal allergen challenge responses in adults with allergic rhinitis.

Authors:  Charles T Pantin; Thomas Southworth; Kristiane Wetzel; Dave Singh
Journal:  Clin Pharmacol       Date:  2019-05-13

7.  Are Markers of Allergic Inflammation in Grass Pollen Allergy Influenced by H1 Antihistamines?

Authors:  Ioana Corina Bocsan; Ioana Adriana Muntean; Nicolae Miron; Irena Pintea; Carmen Teodora Dobrican; Corina Ureche; Anca Dana Buzoianu; Diana Deleanu
Journal:  J Clin Med       Date:  2021-12-26       Impact factor: 4.241

8.  In vivo determination of mouse olfactory mucus cation concentrations in normal and inflammatory states.

Authors:  Senthil Selvaraj; Kevin Liu; Alan M Robinson; Victoria A Epstein; David B Conley; Robert C Kern; Claus-Peter Richter
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

9.  Xanthii Fructus inhibits allergic response in the ovalbumin-sensitized mouse allergic rhinitis model.

Authors:  Nam-Gil Gwak; Eun-Young Kim; Bina Lee; Jae-Hyun Kim; Yong-Seok Im; Ka-Yeon Lee; Chang Jun-Kum; Ho-Seok Kim; Hyun-Joo Cho; Hyuk-Sang Jung; Youngjoo Sohn
Journal:  Pharmacogn Mag       Date:  2015-10       Impact factor: 1.085

10.  How Could We Influence Systemic Inflammation in Allergic Rhinitis? The Role of H1 Antihistamines.

Authors:  Ioana Adriana Muntean; Ioana Corina Bocsan; Nicolae Miron; Anca Dana Buzoianu; Diana Deleanu
Journal:  Oxid Med Cell Longev       Date:  2018-06-12       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.